A randomized, double-blind study comparing LY2216684 and placebo in the treatment of major depressive disorder - Pangallo, Beth; Dellva, Mary Anne; D’Souza, Deborah N.; Essink, Beal; Russell, James; Goldberger, Celine (Journal of psychiatric research, 2011)
Keywords: Adolescent; Adrenergic Uptake Inhibitors - administration & dosage; Adrenergic Uptake Inhibitors - adverse effects; Adult; Adult and adolescent clinical studies; Aged; Antidepressive Agents - administration & dosage; Antidepressive Agents - adverse effects; Biological and medical sciences; Depression; Depressive Disorder, Major - drug therapy; Depressive personality disorders; Diagnostic and Statistical Manual of Mental Disorders; Disability; Discontinued; Dose-Response Relationship, Drug; Double-Blind Method; Efficacy; Female; Humans; LY2216684; Major depressive disorder; Male; Medical sciences; Middle Aged; Mood disorders; Morpholines - administration & dosage; Morpholines - adverse effects; Norepinephrine; Phenylethyl Alcohol - administration & dosage; Phenylethyl Alcohol - adverse effects; Phenylethyl Alcohol - analogs & derivatives; Psychiatric Status Rating Scales; Psychiatry; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Remission; Safety; Treatment Outcome; Young Adult; Efficacy; Norepinephrine; Safety; Major depressive disorder; LY2216684; Mood disorder; Treatment; Placebo; Neurotransmitter; Double blind study; Depression; Catecholamine